About this webinar:
A small subset of cancer patients respond to immunotherapy, underscoring the pressing need for advancements in this promising field. In this webinar, Dr James Moon addresses the latest breakthroughs in systemic immunotherapy, with a specific emphasis on leveraging novel STING agonist delivery systems.
You will learn how these innovative delivery methods offer strategies to amplify anti-tumor immunity, convert cold tumors into hot ones, and optimize immunotherapies while minimizing immune-related adverse events.
Key takeaways:
- How advanced drug delivery technologies can enhance immunotherapy’s efficacy
- Ways tailored delivery systems can decrease potential toxicities of cancer therapy
- The potential of platform approaches for other innate immune activators, including TLR agonists
About IO360°, the webinar’s associated conference:
IO360º is an annual conference that convenes key stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers. To learn more about IO360, visit io360summit.com.